Suchbegriff wählen

academia

Can European Solutions Allow Equal Access to Rare Disease Drugs in All European Countries?

Wien (OTS) - The pool of patients suffering from an individual rare disease is very small. Drug development in this area is complex and the risk of failure is much higher than for other diseases. Basic research and the search for treatment options is neglected and often not deemed worth the investment. Ninety-five percent of all rare diseases are still without any treatment options. On October 1, 2021, panelists at the European Health Forum Gastein took a closer look at this issue and discussed potential future

Can European Solutions Allow Equal Access to Rare Disease Drugs in All European Countries?

Wien (OTS) - The pool of patients suffering from an individual rare disease is very small. Drug development in this area is complex and the risk of failure is much higher than for other diseases. Basic research and the search for treatment options is neglected and often not deemed worth the investment. Ninety-five percent of all rare diseases are still without any treatment options. On October 1, 2021, panelists at the European Health Forum Gastein took a closer look at this issue and discussed potential future

SC Johnson Invites Londoners to Walk Beneath the Ocean’s Surface in The Blue Paradox – An Immersive Experience Exploring the…

London (ots/PRNewswire) - Two-week educational event opens to the public (15-27th September) in White City, with free tickets available at BlueParadox.com SC Johnson, the maker of household consumer brands such as Mr Muscle®, Ecover® and Duck®, is launching The Blue Paradox, an immersive educational experience with 360-degree digital projections that invites the public to walk beneath the ocean's surface to explore the impact plastic waste has on our planet's most valuable natural resource and to better understand how

100+ Global Enterprises Take Advantage of Infosys Living Labs to Accelerate their Digital Innovation Agenda

Bengaluru, India (ots/PRNewswire) - Infosys Living Labs is delivering digital innovation as-a-service to help them meet next normal consumer expectations Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that Infosys Living Labs is driving the digital innovation agenda for over 100 global enterprises. With Infosys Living Labs, businesses can leverage on-demand multi-tiered digital infrastructure, comprising technology, processes, people,

Merck and BioMed X Institute Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

Darmstadt, Germany (ots/PRNewswire) - - Merck to support up to six additional research projects at the BioMed X Institute in Heidelberg within the next six years - Call for application for a global crowdsourcing project, 'Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging' Merck, a leading science and technology company, today announced the extension of its ongoing collaboration with BioMed X, Heidelberg, Germany. Under the new agreement, Merck will start up to six additional research projects at the

Infosys and Ellen MacArthur Foundation Partner to Drive Forward Circular Economy

London (ots/PRNewswire) - Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, has partnered with the Ellen MacArthur Foundation charity. The organisations will work together to accelerate the global transition to a circular economy. The Foundation works with its Network of Strategic Partners, Partners, and Members. Infosys has joined the Network as a Partner. The Network includes some of the world's leading and most influential organisations, including businesses, governments,

G20 at a Glance: The role of the civil society in the G20 Process

Riyadh, Saudi Arabia (ots/PRNewswire) - The G20 has a strong tradition of working with a broad range of organizations to bring different perspectives on socioeconomic challenges to the G20 table. The Engagement Groups are independent collectives that are led by civil society organizations and the business sector from the host country. They work with other organizations from G20 countries to develop policy recommendations that are formally submitted, through the G20 Presidency, to G20 leaders for consideration.

Launched Today: Infosys Cobalt – A Set of Services, Solutions, and Platforms for Enterprises to Accelerate their Cloud Journey

Bengaluru, India (ots/PRNewswire) - - Offers over 14,000 cloud assets and over 200 industry cloud solution blueprints Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, today launched Infosys Cobalt - a set of services, solutions, and platforms that acts as a force multiplier for cloud-powered enterprise transformation. Infosys Cobalt helps businesses redesign the enterprise, from the core, and also build new cloud-first capabilities to create seamless experiences in public,

IQM Makes First Expansion Move; Creates Subsidiary in Germany to Drive Quantum Hardware-software Co-design

Espoo, Finland (ots/PRNewswire) - - Top quantum expert tapped to lead the new facility IQM Finland Oy (IQM), today announced an expansion through the establishment of its first subsidiary company, IQM Germany, located in Munich. The company also announced the appointment of renowned quantum computing and quantum technology expert, Prof. Enrique Solano as CEO of IQM Germany. IQM is an emerging hardware leader focused on developing quantum computers based on scalable high-speed superconducting quantum processors. The

Zentiva Celebrates The Parc’s Impressive Scientific Track Record in 2019

Prague (ots/PRNewswire) - Zentiva welcomed The Pharmaceutical Applied Research Center (The Parc) to their Prague headquarters to celebrate the first anniversary of The Parc Awards. The Parc is a unique research platform designed to prepare future generations of pharmaceutical scientists and engineers. Twenty-nine students are currently included in the program and an outstanding track record has been achieved in 2019: 16 publications, one patent application, 30 conference presentations, six plenary and keynote lectures,